Inter-rater and Intra-rater Reliability of the Global Eyebrow Assessment Scale
1 other identifier
observational
112
1 country
1
Brief Summary
This study evaluated the inter- and intra-rater reliability of the GEBA Scale with photonumeric guide for the assessment of overall eyebrow fullness. There is no treatment (intervention) associated with this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
August 5, 2011
CompletedFirst Posted
Study publicly available on registry
August 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2011
CompletedResults Posted
Study results publicly available
October 29, 2012
CompletedOctober 29, 2012
September 1, 2012
1 month
August 5, 2011
September 27, 2012
September 27, 2012
Conditions
Outcome Measures
Primary Outcomes (2)
Inter-rater Reliability of Physician Raters Using the Global Eyebrow Assessment (GEBA) Scale
Inter-rater agreement (among raters) of the GEBA scores (1=very sparse, 2=sparse, 3=full, 4=very full) to assess eyebrow fullness was evaluated using Kendall's coefficient of concordance (Kendall's W). Each of 7 raters scored 112 subjects' eyebrows using the GEBA Scale at 2 different time points at day 1. The overall inter-rater agreement for Kendall's W for all raters combined was estimated based on the average of the scores from those 2 different time points. The degree of agreement of the point estimates of Kendall's W was interpreted according to the reference range scale that was pre-defined as: ≤ 0: poor, 0.00-0.20: slightly, 0.21-0.40: fair, 0.41-0.60: moderate, 0.61-0.80: substantial and 0.81-1:00: almost perfect. The 95% confidence interval for Kendall's W was provided.
Day 1
Intra-rater Reliability of Physician Raters Using the Global Eyebrow Assessment (GEBA) Scale
Intra-rater (within raters) agreement of the GEBA scores (1=very sparse, 2=sparse, 3=full, 4=very full) to assess eyebrow fullness was evaluated by weighted Kappa statistics. Weighted Kappa statistics were calculated for each of 7 raters who evaluated 112 subjects using GEBA scale, assessing agreement between 2 different time points at day 1. The overall intra-rater agreement for Kappa statistics for all raters combined was estimated by pooling Kappa statistics for each rater using a chi-square statistic. The degree of agreement of the point estimates of Kappa statistics was interpreted according to the reference range scale that was predefined as: ≤ 0: poor, 0.00-0.20: slightly, 0.21-0.40: fair, 0.41-0.60: moderate, 0.61-0.80: substantial and 0.81-1:00: almost perfect. The 95% confidence interval for Kappa statistics was provided.
Day 1
Study Arms (1)
All Participants
Healthy volunteers. No treatment (intervention) was received.
Interventions
Eligibility Criteria
Healthy Volunteers
You may qualify if:
- Willing to remove makeup and jewelry at each visit
- Willing to have photographs taken of the facial area
You may not qualify if:
- Permanent eyebrow makeup (i.e., tattooing) or eyebrow implants of any kind
- Eyebrow extension application within 3 months of study entry
- Eyebrow tint or dye application within 2 months of study entry
- Eyebrow grooming (i.e., tweezing, waxing, or threading) between visits that is not part of the current routine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Allerganlead
Study Sites (1)
Unknown Facility
Newport Beach, California, United States
Results Point of Contact
- Title
- Therapeutic Area Head,
- Organization
- Allergan, Inc
Study Officials
- STUDY DIRECTOR
Medical Director
Allergan
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 5, 2011
First Posted
August 9, 2011
Study Start
August 1, 2011
Primary Completion
September 1, 2011
Study Completion
September 1, 2011
Last Updated
October 29, 2012
Results First Posted
October 29, 2012
Record last verified: 2012-09